What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
Apr 13 2021;9(4)doi:10.3390/biomedicines9040418 Cademartiri F, Balestrieri A, Cau R, et al
a context-dependent reversal of this role under the tested conditions remains mechanistically unresolved
The peptide may prove most valuable as an adjunct to post-surgical rehabilitation or for managing small, stable tears conservatively
It a proprietary formulation and is not individually approved by the U.S
Evidenza scientifica clinicamente comprovata Rilevanza efficace per il tuo obiettivo Sicurezza e qualit testato GMP Il tuo prodotto Integrato in ogni formula *Risposte di ricercatori medici indipendenti e medici abilitati What is in the Certificate of Analysis (CoA) for BPC-157
